| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Precigen Q1 2024 Earnings Preview | 3 | Seeking Alpha | ||
| 29.04. | PRECIGEN, INC. - 10-K/A, Annual Report | 6 | SEC Filings | ||
| 29.03. | Precigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis | 6 | FiercePharma | ||
| 22.03. | J.P. Morgan cuts Precigen to underweight, cites burn rate | 15 | Seeking Alpha | ||
| 20.03. | Precigen shares hold with $14 target on pivotal trial focus | 17 | Investing.com | ||
| 20.03. | Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript | 6 | Insider Monkey | ||
| 20.03. | Earnings call: Precigen eyes transformative 2024 with PRGN-2012 launch | 8 | Investing.com | ||
| 19.03. | Precigen Inc reports results for the quarter ended in December - Earnings Summary | 8 | Reuters | ||
| 19.03. | PRECIGEN, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 19.03. | Recap: Precigen Q4 Earnings | 2 | Benzinga.com | ||
| 19.03. | PRECIGEN, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.03. | Precigen, Inc.: Precigen Reports Full Year 2023 Financial Results and Business Updates | 59 | PR Newswire | - Significant progress made in the development of the PRGN-2012 AdenoVerse immunotherapy for the treatment of RRP; Precigen plans to submit a BLA under an accelerated approval pathway in the second... ► Artikel lesen | |
| 18.03. | Precigen FY 2023 Earnings Preview | 3 | Seeking Alpha | ||
| 18.03. | Preview: Precigen's Earnings | 2 | Benzinga.com | ||
| 08.02. | PRECIGEN, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 17.01. | EC grants orphan drug designation for Precigen's PRGN-2012 | 12 | Pharmaceutical Technology | ||
| 16.01. | Precigen gets EU orphan drug status for respiratory tract drug | 5 | Seeking Alpha | ||
| 16.01. | Precigen climbs on EU's 'orphan' tag for its respiratory tract disease treatment | 3 | Reuters | ||
| 16.01. | Precigen, Inc.: Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission | 186 | PR Newswire | - Designation is an important step toward bringing this potentially life-changing therapy to European patients -
- EU Orphan Drug Designation is the first regulatory designation for a gorilla adenovector... ► Artikel lesen | |
| 08.01. | PRECIGEN, INC. - 8-K, Current Report | 3 | SEC Filings |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 4.364 |
| BAYER | 3.292 |
| TUI | 3.128 |
| NEL | 2.762 |
| GAMESTOP | 2.370 |
| RHEINMETALL | 2.127 |
| PLUG POWER | 2.067 |
| SIEMENS ENERGY | 1.677 |
| AMC ENTERTAINMENT | 1.505 |
| NVIDIA | 1.441 |
| MERCEDES-BENZ | 1.435 |
| NOVAVAX | 1.394 |
| NORDEX | 1.331 |
| ALIBABA | 1.295 |
| BYD | 1.186 |
| DEUTSCHE BANK | 1.126 |
| VOLKSWAGEN | 1.020 |
| DELIVERY HERO | 1.009 |
| ALLIANZ | 948 |
| RWE | 946 |
| TESLA | 933 |
| AIXTRON SE | 913 |
| PALANTIR TECHNOLOGIES | 901 |
| COMMERZBANK | 891 |
| DEUTSCHE LUFTHANSA | 797 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
